Design Therapeutics (DSGN)
(Delayed Data from NSDQ)
$5.29 USD
-0.12 (-2.22%)
Updated Aug 27, 2025 04:00 PM ET
After-Market: $5.30 +0.01 (0.19%) 5:52 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Design Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
DSGN 5.29 -0.12(-2.22%)
Will DSGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DSGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DSGN
Design Therapeutics (DSGN) Upgraded to Buy: Here's Why
Wall Street Analysts See a 31.33% Upside in Design Therapeutics (DSGN): Can the Stock Really Move This High?
DSGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for DSGN
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference | DSGN Stock News
Stochastic Reached Overbought appears for DSGN after 4.04% move
The technical outlook for DSGN is unchanged after it falls 1.14% on August 25
NR7 appears for DSGN after 2.14% move
DSGN forms 180 Bullish Setup on August 21